Drug delivery to the posterior eye segment is an important challenge in ophthalmology,
because many diseases affect the retina and choroid leading to impaired vision or …

Diabetes is a major cause of visual impairment among working-age adults in the United
States. The proliferative form of diabetic retinopathy is associated with severe vision loss …

Background: Ocular drug delivery is an extremely challenging area due to its restrictive
barrier functionalities. Objective: Drug transport via corneal/non-corneal routes involves …

Intravitreal administration of drugs has raised a large interest during the last two decades
improving the treatment of infectious diseases of the posterior segment of the eye or …

Glaucoma is a leading cause of irreversible visual impairment and blindness, affecting over
76.0 million people worldwide in 2020, with a predicted increase to 111.8 million by 2040 …

Nanotechnology is a new area that presents small sized materials, structures, devices, and
systems in last few decades. We hear about many materials and systems that contain …

Development of new drug candidates and novel delivery techniques for treatment of ocular
diseases has recently accelerated. Treatment of anterior-segment diseases has witnessed …

The present paper concerns both the optimization of dexamethasone (DXM) entrapment and
its release from biodegradable poly (d, l-lactide-co-glycolide)(PLGA) nanoparticles prepared …

Retinal drug delivery is a challenging area in the field of ophthalmic drug delivery. An ideal
drug delivery system for the retina and vitreous humor has not yet been found, despite …

Retinal neuroinflammation, mediated by activated microglia, plays a key role in the
pathogenesis of photoreceptor and retinal pigment epithelial cell loss in age-related macular …